FDA deploys IBS' reservation system
Printer Print Email Email
Bangalore: Fuji Dream Airlines (FDA), a start-up Japanese domestic airline, has selected IBS' iFly reservation system (Res) to manage its inventory and reservation system. The system went live in June, 2009. Through a five year contract, IBS' solution will support FDA to manage passenger reservations, inventory control, fares and departure control functions. iFly Res is a constituent product that forms part of the iFly solution suite for airline passenger services. Till date, 18 airlines have committed to use this product. iFly Res is a comprehensive customer sales and service solution, built on new-generation technology, providing ample capabilities in shopping, pricing, inventory control and web check-in to help airlines best serve their customers through every point of their journey. V K Mathews, Chairman and CEO, IBS Group said, "Our software solutions were always looked upon by established global players in the airline industry as a preferred substitute to their legacy systems. But for a brand-new airline like FDA to have chosen IBS from its first day of operation is very gratifying. This is a significant entry for our passenger reservation system given the highly competitive and demanding nature of the Japanese market." FDA was incorporated in June 2008 under Suzuyo Group. FDA is likely to launch domestic operations by the end of July 2009, with Mt. Fuji Shizuoka airport in central Japan as its base. The Suzuyo Group, established in 1801, is a diversified business group with over 100 companies engaged in trading, commercial distribution, construction, food, information, regional development and airline business.

siliconindia